Article Contents ::
- 1 Details About Generic Salt :: Zolpidem
- 2 Main Medicine Class:: Sedative and hypnotic
- 3 (ZOLE-pih-dem) Ambien Class: Sedative and hypnotic
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Zolpidem
Main Medicine Class:: Sedative and hypnotic
(ZOLE-pih-dem)
Ambien
Class: Sedative and hypnotic
Drugs Class ::
Action Mechanism is unknown but may involve subunit modulation of the aminobutyrate activase (GABA) receptor chloride channel macromolecular complex.
Indications for Drugs ::
Indications Short-term treatment of insomnia.
Drug Dose ::
Route/Dosage
ADULTS: PO 10 mg immediately before bedtime. ELDERLY, DEBILITATED, OR HEPATIC INSUFFICIENCY PATIENTS: An initial 5 mg dose is recommended. Maximum dose: Do not exceed 10 mg.
Contraindication ::
Contraindications Standard considerations.
Drug Precautions ::
Precautions
Pregnancy: Category B. Lactation: Excreted in breast milk. Children: Safety and efficacy not established. Elderly/debilitated patients: Closely monitor these patients. Recommended dosage is 5 mg. Duration of therapy: Generally limit to 7 to 10 days, re-evaluate patient if to be taken for > 2 to 3 weeks. Abrupt discontinuation: Has been associated with withdrawal symptoms similar to those associated with other CNS depressant drugs. Hepatic function impairment: Dosage modification may be necessary. Abuse/Dependence: Use with caution in patients with history of drug or alcohol abuse, depression, or suicidal tendencies. Respiratory depression: Use with caution in patients with compromised respiratory function.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Palpitations. CNS: Amnesia; daytime drowsiness; dizziness; headache; lethargy; “drugged feelings”, lightheadedness; depression; abnormal dreams; ataxia; confusion; euphoria; insomnia; vertigo. EENT: Sinusitis; pharyngitis; diplopia, abnormal vision. GI: Diarrhea; constipation; dry mouth. OTHER: Allergy; back pain; flu-like symptoms; chest pain.
Drug Mode of Action ::
Action Mechanism is unknown but may involve subunit modulation of the aminobutyrate activase (GABA) receptor chloride channel macromolecular complex.
Drug Interactions ::
Interactions
Food: Reduces absorption of zolpidem. Ritonavir: Possible severe sedation and respiratory depression.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note hepatic impairment, debilitated status, and respiratory status.
- Ensure that side rails are raised after administration.
- Assist patient with ambulation after administration of drug.
- Assess sleep patterns prior to and during therapy.
- Assess for the development of abnormal thinking or behavior changes during therapy.
|
Drug Storage/Management ::
Administration/Storage
- Available only in PO tablet form.
- Administer immediately before bedtime on an empty stomach.
- Store at room temperature (19° to 30°C; 66° to 86°F).
- Keep in tightly sealed, child-proof container.
Drug Notes ::
Patient/Family Education
- Advise patient to take immediately before going to bed. Advise patient to take on an empty stomach.
- Warn patient to never stop taking medication suddenly; withdrawal symptoms may develop.
- Instruct patient to avoid alcohol and other CNS depressants while taking drug.
- Caution patients to avoid driving or other tasks requiring alertness, coordination, or physical dexterity due to drowsiness that may occur.
- Instruct patient to take medication exactly as directed; do not increase dosage without health care provider approval.
- Emphasize the importance of follow-up appointments to monitor progress of therapy.